View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 3 / Ibrutinib 420, Chronic Lymphocytic Leukemia, Richter Transformation, Cycle 2+
Protocol-ID: 2852 V1.0 (Mini), NIVO3/IBRU420, CLL (Richter Transformation), C2+Indication(s)
- NHL, B-cell type, transformed Lymphoma (Richter-Transformation, DLBCL)
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 12.03.2025